Endo International plc

5.89-0.3700-5.91%Vol 4.19M1Y Perf 48.99%
Apr 19th, 2021 16:00 DELAYED
BID5.75 ASK5.94
Open6.12 Previous Close6.26
Pre-Market- After-Market5.90
 - -  0.01 0.17%
Target Price
8.13 
Analyst Rating
Hold 2.75
Potential %
38.03 
Finscreener Ranking
★★★     49.85
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★★+     53.79
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★+     50.74
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Market Cap1.36B 
Earnings Rating
Neutral
Price Range Ratio 52W %
38.88 
Earnings Date
7th May 2021

Today's Price Range

5.836.21

52W Range

2.7110.89

5 Year PE Ratio Range

-1.80-1.20

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-3.60%
1 Month
-27.91%
3 Months
-16.22%
6 Months
1.55%
1 Year
48.99%
3 Years
6.90%
5 Years
-79.28%
10 Years
-84.81%

TickerPriceChg.Chg.%
ENDP5.89-0.3700-5.91
AAPL134.840.68000.51
GOOG2 302.404.64000.20
MSFT258.74-2.0000-0.77
XOM56.48-0.1800-0.32
WFC43.880.04000.09
JNJ162.690.45000.28
FB302.24-3.9400-1.29
GE13.460.07000.52
JPM152.65-0.6500-0.42
Earnings HistoryEstimateReportedSurprise %
Q04 20200.500.7550.00
Q03 20200.140.52271.43
Q02 20200.350.6585.71
Q01 20200.540.9575.93
Q04 20190.570.7429.82
Q03 20190.530.6013.21
Q02 20190.470.5210.64
Q01 20190.420.5326.19
Earnings Per EndEstimateRevision %Trend
3/2021 QR0.48-4.00Negative
6/2021 QR0.47-7.84Negative
12/2021 FY2.12-7.83Negative
12/2022 FY2.111.93Positive
Next Report Date7th May 2021
Estimated EPS Next Report0.48
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume4.19M
Shares Outstanding230.50M
Trades Count16.29K
Dollar Volume32.28M
Avg. Volume3.99M
Avg. Weekly Volume3.01M
Avg. Monthly Volume3.33M
Avg. Quarterly Volume3.70M

Endo International plc (NASDAQ: ENDP) stock closed at 5.89 per share at the end of the most recent trading day (a -5.91% change compared to the prior day closing price) with a volume of 4.19M shares and market capitalization of 1.36B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 3397 people. Endo International plc CEO is Blaise Coleman.

The one-year performance of Endo International plc stock is 48.99%, while year-to-date (YTD) performance is -17.97%. ENDP stock has a five-year performance of -79.28%. Its 52-week range is between 2.71 and 10.89, which gives ENDP stock a 52-week price range ratio of 38.88%

Endo International plc currently has a PE ratio of 7.90, a price-to-book (PB) ratio of 2.64, a price-to-sale (PS) ratio of 0.65, a price to cashflow ratio of 3.70, a PEG ratio of 2.32, a ROA of 1.89%, a ROC of -% and a ROE of -23.12%. The company’s profit margin is 2.00%, its EBITDA margin is 35.50%, and its revenue ttm is $2.08 Billion , which makes it $9.04 revenue per share.

Of the last four earnings reports from Endo International plc, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.48 for the next earnings report. Endo International plc’s next earnings report date is 07th May 2021.

The consensus rating of Wall Street analysts for Endo International plc is Hold (2.75), with a target price of $8.13, which is +38.03% compared to the current price. The earnings rating for Endo International plc stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Endo International plc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Endo International plc has a Sell technical analysis rating based on Technical Indicators (ADX : 20.29, ATR14 : 0.57, CCI20 : -102.02, Chaikin Money Flow : -0.25, MACD : -0.64, Money Flow Index : 26.82, ROC : -20.51, RSI : 44.52, STOCH (14,3) : 3.23, STOCH RSI : 0.00, UO : 38.28, Williams %R : -96.77), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Endo International plc in the last 12-months were: Blaise A. Coleman (Option Excercise at a value of $0), Jack Boyle (Option Excercise at a value of $0), Mark Bradley (Option Excercise at a value of $0), Matthew J. Maletta (Option Excercise at a value of $0), Patrick Barry (Option Excercise at a value of $0), Paul V. Campanelli (Option Excercise at a value of $0), Shane M. Cooke (Sold 17 290 shares of value $149 559 ), William P. Montague (Sold 9 033 shares of value $78 406 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (27.27 %)
3 (25.00 %)
2 (16.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
6 (54.55 %)
7 (58.33 %)
8 (66.67 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
2 (18.18 %)
2 (16.67 %)
2 (16.67 %)
Summary RatingHold
2.75
Hold
2.78
Hold
2.94

Endo International plc

After a string of acquisitions and divestitures, Endo is a specialty pharmaceutical company with a considerable presence in pain management. The acquisitions of Auxilium and Par increased the company's presence in urology and generics, respectively.

CEO: Blaise Coleman

Telephone: +353 12682000

Address: Simmonscourt Road, Ballsbridge, Dublin 4, , IE

Number of employees: 3 397

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

44%56%

Bearish Bullish

38%62%

Bearish Bullish

48%52%

News

Stocktwits